Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.
Clinical trial NCT03213301 · COMPLETED
Trial details
- NCT number
- NCT03213301
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-28
- Primary completion
- 2021-06-11
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.